Skip to content

SION SION Retained Earnings

Retained Earnings at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$14.59B+42.3%
AbbVie logo
AbbVieABBV
-$17.87B-87.6%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$175.89M-25.8%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
-$2.23B-25.9%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
-$2.18B-30.4%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$589.6M+11,225%

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.86B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's retained earnings?
SION (SION) reported retained earnings of -$283.13M in Q1 2026.
How has SION's retained earnings changed year-over-year?
SION's retained earnings decreased by 43.3% year-over-year, from -$197.57M to -$283.13M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.